Press Centre
Press Releases
Availability of Report & Accounts
Phynova Group plc
("Phynova" or the "Company")
Availability of Report & Accounts
The Company announces that the report and accounts for the year ended 30 September 2008 has now been posted to shareholders and is available from the Company´s website www.phynova.com.
For further information, please contact:
Phynova Group plc
John Pool (Executive Chairman)
Tony Mills (CEO Phynova Limited)
Robert Miller (CEO Phynova China Limited)
Tel: 01993 880700
John East & Partners Limited
Simon Clements
Tel: 020 7618 2200
Capital MS&L
Mary Clark/Anna Mitchell
Tel: 020 7 307 5330
Notes to editors:
About Phynova
Phynova (AIM: PYN) is a UK company developing new prescription pharmaceuticals derived from plants used in Chinese medicines. The Company is focused on viral and bacterial diseases, metabolic diseases and cancer. Phynova´s lead product for hepatitis C has now completed a Phase I/II trial in the US. Two further products, for fatty liver disease and post-operative ileus, are targeted for entry to the clinic and there are a further four products in preclinical development.
For further information please visit www.phynova.com.
11/03/2009
<< Back | See all current Press releses